U.S. FDA clears software update for Hyperfine's Optive AI

The U.S. Food and Drug Administration (FDA) has cleared Hyperfine's first update to its Optive AI software.

The update consists of a multi-direction diffusion-weighted imaging (DWI) sequence for its portable MRI system, Swoop system, the company said. The sequence acquires and averages signals in a similar way to a method used in high-field MRI scanners, to produce cleaner, more consistent images, according to Hyperfine.

The multi-direction DWI sequence is the first of a number of advancements Hyperfine plans to develop for Optive AI, it noted.